Laidlaw Wealth Management LLC Sorrento Therapeutics, Inc. Transaction History

Laidlaw Wealth Management LLC

  • $189 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$2.0 - $4.9 $38,360 - $93,982
-19,180 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$7.41 - $10.99 $22,230 - $32,970
3,000 Added 18.54%
19,180 $146,000
Q4 2020

Feb 16, 2021
BUY
$5.76 - $11.95 $2,361 - $4,899
410 Added 2.6%
16,180 $110,000
Q3 2020

Nov 16, 2020
BUY
$6.17 - $18.82 $97,300 - $296,791
15,770 New
15,770 $176,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Laidlaw Wealth Management LLC Portfolio

Follow Laidlaw Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laidlaw Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email